07:00 , Oct 5, 2015 |  BC Week In Review  |  Financial News

BioTime completes direct public offering

BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX), Alameda, Calif.   Business: Gene/Cell therapy, Pulmonary, Diagnostic   Date completed: 2015-10-02   Type: Direct public offering   Raised: $5.1 million   Shares: 1.6 million   Price: $3.19   Shares...
07:00 , Sep 21, 2015 |  BC Week In Review  |  Financial News

BioTime completes private placement

BioTime Inc. (NYSE-M:BTX), Alameda, Calif.   Business: Gene/Cell therapy, Pulmonary, Diagnostic   Date completed: 2015-09-14   Type: Private placement   Raised: $8.6 million   Shares: 2.6 million   Price: $3.29   Shares after offering: 81.9...
07:00 , Oct 13, 2014 |  BC Week In Review  |  Financial News

BioTime completes direct public offering

BioTime Inc. (NYSE-M:BTX), Alameda, Calif.   Business: Gene/Cell therapy, Pulmonary, Diagnostic   Date completed: 2014-10-09   Type: Direct public offering   Raised: $29.4 million   Shares: 9.4 million   Price: $3.12   Shares after offering:...